ITPを有する日本人被験者を対象としたAMG 531の非盲検延長試験

基本情報

NCT ID

NCT00440037

ステータス

完了

試験のフェーズ

第2/第3相

試験タイプ

介入

目標被験者数

44

治験依頼者名

Kyowa Kirin Co., Ltd.

概要

The purpose of this study is to assess the safety and efficacy of long term dosing of AMG 531 in thrombocytopenic Japanese subjects with ITP. It is anticipated that AMG 531 will be a safe and well tolerated in long term treatment and that AMG 531 will effectively raise and maintain platelet counts to a desired therapeutic range, when individual dose adjustments based on platelet counts are permitted. This study is available to subjects who have completed any previous AMG 531 ITP study in Japan and meet the eligibility criteria of this study.

対象疾患

介入

依頼者（Sponsor）